Results 71 to 80 of about 42,559 (244)

Understanding excessive sleep in people with psychotic disorders

British Journal of Clinical Psychology, EarlyView.
Abstract Background There has been increasing attention to sleep disturbances such as insomnia in psychosis, due to its impact on symptoms, well‐being, and recovery. However, excessive sleep and extended sleep duration are common in psychosis (partly linked to sedating antipsychotic medication) and have been relatively neglected, despite plausible ...
Kate Robbins, Joanne Hodgekins, Sarah Reeve   +2 more
wiley   +1 more source

Clozapine in the community [PDF]

British Journal of Psychiatry, 1992
M, Phelan, G, Strathdee, K, Jones
openaire   +2 more sources

Cannabigerol reverses mechanical allodynia through α2A‐adrenergic modulation of thalamocortical signaling in chemotherapy‐induced neuropathy

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Chemotherapy‐induced peripheral neuropathy (CIPN) is a prevalent and treatment‐resistant side effect of platinum‐based chemotherapy, characterised by mechanical allodynia. Cannabigerol (CBG), a non‐psychoactive cannabinoid, has shown antinociceptive potential, but its site and mechanism of action remain unclear.
Quinn W. Wade, Nathan Morris, Diana E. Sepulveda, Alonso Cortez‐Resendiz, Christopher Brandl, Jennifer E. Lausch, Mariya Starostina, Nicholas M. Graziane   +7 more
wiley   +1 more source

What is the current scope of research assessing patients’ and clinicians’ perspectives on clozapine treatment? A comprehensive scoping review

BMJ Open
Objectives Clozapine is continuously underused. The existing systematic reviews addressing barriers to clozapine prescribing primarily focus on clinical staff’s attitudes and perceived barriers to prescribing.
Jimmi Nielsen, Erik Simonsen, Ole Jakob Storebø, Michelle Iris Jakobsen, Stephen F Austin, Julie Perrine Schaug   +5 more
doaj   +1 more source

Genetics of Clozapine-Associated Neutropenia: Recent Advances, Challenges and Future Perspective [PDF]

, 2019
Sophie E. Legge, James Walters
openalex   +1 more source

Author response for "Clozapine Levels as a Predictor for Therapeutic Response: A Systematic Review and Meta‐Analysis"

, 2021
Dan Siskind, Meghna Sharma, Mrinal Pawar, Ella Pearson, Elias Wagner, Nicola Warren, Steve Kisely   +6 more
openalex   +1 more source

Clozapine-induced myocarditis: a case report and literature review [PDF]

, 2022
I. Angélico Ferreira, M.A. González Fé, M.D.M. Marqués Pastor, C. Roset, Lucas Antônio Fernandes Torres   +4 more
openalex   +1 more source

Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials

British Journal of Pharmacology, EarlyView.
Abstract Schizophrenia is regarded as a complex and heterogeneous psychiatric disorder, characterised by diverse symptoms and comorbidities, which complicate both clinical management and drug development. Current pharmacological treatment, primarily based on dopamine D2 receptor antagonism or partial agonism, which has not markedly progressed since the
Thi Viet Ha Nguyen, Declan P. McKernan, John P. Kelly   +2 more
wiley   +1 more source

Documentation of Drug and Non‐Drug Allergies in Public Hospital Electronic Health Records: A National Survey

Clinical &Experimental Allergy, EarlyView.
These surveys reveal inconsistent electronic patient record (EPR) systems and poor documentation standards for non‐drug allergies, leading to high incident rates and misclassification. Standardised documentation, improved training and user‐friendly EPR platforms are urgently needed to enhance patient safety and reduce allergy‐related incidents across ...
Melvin Lee Qiyu, Erika Harnik, Claudia Gore   +2 more
wiley   +1 more source

COVID-19 disease outcomes in patients receiving clozapine versus other antipsychotics: a national study in Qatar

Frontiers in Psychiatry
BackgroundClozapine has immunomodulatory effects that raised concerns about its potential to exacerbate severe COVID-19. This study examines whether clozapine use is associated with worse COVID-19 outcomes in patients with schizophrenia.MethodsThis ...
Dalia Albahari, Oraib Abdalla, Shatha Mahmud Ismail Alqam, Mohammed Faisal Hamad Mohammed, Mohamed Ali Siddig Ahmed, Ovais Wadoo, Ovais Wadoo   +6 more
doaj   +1 more source